CareCloud vs Veradigm
Two End-to-End RCM vendors, side by side. Facts from public sources; judgments are ours.
At a glance
Derived from public facts · a rough scale, not a ranking
| CareCloud | Veradigm | |
|---|---|---|
| Pricing model | Percent of collections · Software also sold by subscription | Enterprise contract (custom) · Varies by product line |
| Speed to go live | Billing transition and setup, one to three months | Clearinghouse light; EHR and RCM heavier |
| Automation model | Tech-enabled service · Offshore RCM teams plus own software | Software platform · Software plus data network and services |
| Built for | Small practices, Mid-size groups, Billing companies | Small practices, Mid-size groups, Enterprise systems, Payers |
| Security posture | HIPAA | SOC 2 Type II, HIPAA |
| Company maturity | 27 yrs (est. 1999) | 40 yrs (est. 1986) |
| Financial backing | Public (NASDAQ: CCLD) | Public (OTC: MDRX) |
| Named customers | 1 named | None public |
| Published results | Specific numbers public | No public numbers |
| Documented integrations | 3 listed | 4 listed |
| Third-party validation | None found | None found |
Bottom line
- Pick CareCloud if you run an ambulatory group and want low-cost outsourced billing bundled with workable cloud PM/EHR software.
- Pick Veradigm if you want a proven clearinghouse and ambulatory RCM stack from one vendor and can tolerate its corporate and financial-reporting turbulence.
CareCloud
Outsourced RCM plus cloud PM and EHR for ambulatory groups
- Founded
- 1999
- HQ
- Somerset, NJ
- Stage
- Public (NASDAQ: CCLD)
- Raised
- n/a
What it does
- Outsourced medical billing and RCM
- Cloud practice management and EHR
- AI tools: front desk agent, note generation
- Credentialing and enrollment services
- Hospital EHR and supply chain via Medsphere
- Analytics and benchmarking (HFMA MAP App)
Where it's strong
- Percent-of-collections pricing with a large offshore delivery team keeps costs low for small groups.
- Newly profitable, with FY2025 revenue of $120.5 million and positive GAAP EPS.
- Aggressive AI investment (front desk voice agent, documentation) is shipping, not just slideware.
What buyers should weigh
- Growth has come partly from acquisitions (Medsphere, MAP App), so product integration is uneven.
- The company went through financial distress and dividend suspensions before its 2024-2025 turnaround.
- Offshore-heavy delivery means service quality varies by account team.
Named customers
Memorial Hospital
Integrations
Veradigm
Ambulatory RCM, clearinghouse network, and healthcare data at scale
- Founded
- 1986
- HQ
- Chicago, IL
- Stage
- Public (OTC: MDRX)
- Raised
- n/a
What it does
- Payerpath clearinghouse serving 300,000+ providers
- Outsourced RCM services (Koha Health acquisition)
- Veradigm EHR and Practice Fusion for ambulatory care
- AI Ambient Scribe for clinical documentation
- Payer analytics and risk adjustment
- Real-world data for life sciences research
Where it's strong
- Payerpath is repeatedly ranked the top physician claims clearinghouse by Black Book.
- One vendor covers EHR, clearinghouse, RCM services, and an ambient scribe for ambulatory groups.
- Its provider network gives it data assets few RCM vendors can match.
What buyers should weigh
- Accounting failures got the stock delisted from Nasdaq in 2024; it still trades OTC while restating financials.
- Strategic uncertainty lingers after an abandoned sale process and repeated leadership changes.
- The EHR products are legacy Allscripts assets with slower innovation than newer rivals.
Integrations
Compare against the rest of End-to-End RCM
Deciding between these two?
First Pass tracks End-to-End RCM every week: funding, launches, and what changed since this page was written.